Literature DB >> 29380890

Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation.

Clara García-Carro1, Christina Dörje2, Anders Åsberg2,3, Karsten Midtvedt2, Helge Scott4, Finn P Reinholt4, Hallvard Holdaas2, Anna V Reisaeter2, Daniel Seron1.   

Abstract

Kidney allograft inflammation is associated with proinflammatory modifications of peripheral blood mononuclear cells, suggesting that renal inflammation contributes to systemic inflammation. Thus, the aim of this study was to evaluate the relationship between subclinical inflammation in surveillance biopsies performed at 1 year and systemic inflammation assessed by C-reactive protein (CRP) levels at the time of biopsy. We analyzed 544 surveillance biopsies performed at 1 year that were classified as normal (n = 368), borderline (n = 148), or subclinical rejection (SCR) (n = 28). CRP levels were divided into quartiles. Patients in 1st, 2nd, and 3rd quartile were classified as low CRP (n = 408) and patients in the 4th quartile as high CRP (n = 136). Univariate analysis showed that the proportion of patients with SCR was higher in the high CRP group (10.3% vs 3.4%, P = 0.0067). Multivariate analysis showed that independent predictors of high CRP were body mass index (odds ratio [OR] 1.072 and 95% confidence interval [CI] 1.027-1.119), a positive urine culture at the day of the biopsy (OR 2.760 and 95% CI 1.205-6.323), and the presence of SCR at 1-year surveillance biopsy (OR 7.260 and 95% CI 3.530-14.935). In summary, we describe that subclinical acute rejection constitutes an independent predictor of systemic inflammation as measured by CRP.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  C-reactive protein; graft inflammation; surveillance allograft biopsy; systemic inflammation

Mesh:

Substances:

Year:  2018        PMID: 29380890     DOI: 10.1111/ctr.13196

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  3 in total

1.  Growth hormone treatment in the pre-transplant period is associated with superior outcome after pediatric kidney transplantation.

Authors:  Celina Jagodzinski; Sophia Mueller; Rika Kluck; Kerstin Froede; Leo Pavičić; Jutta Gellermann; Dominik Mueller; Uwe Querfeld; Dieter Haffner; Miroslav Zivicnjak
Journal:  Pediatr Nephrol       Date:  2021-09-20       Impact factor: 3.651

2.  Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict Acute Cellular Rejection in the Kidney Allograft.

Authors:  Mario Naranjo; Akanksha Agrawal; Abhinav Goyal; Janani Rangaswami
Journal:  Ann Transplant       Date:  2018-07-10       Impact factor: 1.530

3.  Elevated Terminal C5b-9 Complement Complex 10 Weeks Post Kidney Transplantation Was Associated With Reduced Long-Term Patient and Kidney Graft Survival.

Authors:  Bartlomiej J Witczak; Søren E Pischke; Anna V Reisæter; Karsten Midtvedt; Judith K Ludviksen; Kristian Heldal; Trond Jenssen; Anders Hartmann; Anders Åsberg; Tom E Mollnes
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.